InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
81.99
(
-0.17%
)
Bitcoin
66,182.53
(
-0.68%
)
Post# of 252217
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: None

Friday, 02/02/2018 2:02:38 PM

Friday, February 02, 2018 2:02:38 PM

Post# of 252217
NKTR:

I saw some tweets that NKTR is seeking a sale (take them for whatever they are worth). Yesterday a big spike too.

Reminds me A LOT of what happened with TKT. They were looking to sell a secondary program, Dynepo (Erythropoietin). Michael Astrue was interested in raising cash and preferred selling all rights for maximum cash... What happened was Shire instead wanted the whole company. I don't think the same will happen with Robin as what transpired with Astrue. He was rather upset (He thought they should wait on a sale with Elaprase data expected shortly).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up